1. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
    Cohen-Eliav M, Golan-Gerstl R, Siegfried Z, Andersen CL, Thorsen K, Orntoft TF, Mu D, Karni R.
    J Pathol. 2012 Nov 6. | Pubmed
  2. Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors.
    Das TK, Sangodkar J, Negre N, Narla G, Cagan RL.
    Oncogene. 2012 Aug 13. | Pubmed
  3. A genome-wide RNAi screen reveals a trio-regulated rho GTPase circuitry transducing Mitogenic signals initiated by G protein-coupled receptors.
    Vaqué JP, Dorsam RT, Feng X, Iglesias-Bartolome R, Forsthoefel DJ, Chen Q, Debant A, Seeger MA, Ksander BR, Teramoto H, Gutkind JS.
    Mol Cell. 2012 Nov 20. pii: S1097-2765(12)00895-7. | Pubmed
  4. CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.
    Desotelle J, Truong M, Ewald J, Weeratunga P, Yang B, Huang W, Jarrard D.
    J Urol. 2012 Nov 19. pii: S0022-5347(12)04807-0. | Pubmed
  5. Deregulation of MTDH gene expression in gastric cancer.
    Baygi ME, Nikpour P.
    Asian Pac J Cancer Prev. 2012;13(6):2833-6. | Pubmed
  6. Specific miRNA stabilization by Gld2-catalyzed monoadenylation.
    D'Ambrogio A, Gu W, Udagawa T, Mello CC, Richter JD.
    Cell Rep. 2012 Nov 28. pii: S2211-1247(12)00378-6. | Pubmed
  7. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.
    Favaro E, Bensaad K, Chong MG, Tennant DA, Ferguson DJ, Snell C, Steers G, Turley H, Li JL, Günther UL, Buffa FM, McIntyre A, Harris AL.
    Cell Metab. 2012 Dec 5;16(6):751-64. | Pubmed
  8. Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.
    Huang W, Bei L, Eklund EA.
    Leuk Lymphoma. 2012 Sep 5. | Pubmed
  9. Derailed estrogen signaling and breast cancer: an authentic couple.
    Manavathi B, Dey O, Gajulapalli VN, Bhatia RS, Bugide S, Kumar R.
    Endocr Rev. 2012 Sep 4. | Pubmed
  10. Opposite role of kindlin-1 and kindlin-2 in lung cancers.
    Zhan J, Zhu X, Guo Y, Wang Y, Wang Y, Qiang G, Niu M, Hu J, Du J, Li Z, Cui J, Ma B, Fang W, Zhang H.
    PLoS One. 2012;7(11):e50313. | Pubmed
  11. DRAK2 participates in a negative feedback loop to control TGF-β/smads signaling by binding to type I TGF-β receptor.
    Yang KM, Kim W, Bae E, Gim J, Weist BM, Jung Y, Hyun JS, Hernandez JB, Leem SH, Park T, Jeong J, Walsh CM, Kim SJ.
    Cell Rep. 2012 Nov 29;2(5):1286-99. | Pubmed
  12. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
    Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, Lessnick SL.
    Oncogene. 2012 Nov 26. | Pubmed
  13. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions.
    Chen L, Chen DT, Kurtyka C, Rawal B, Fulp WJ, Haura EB, Cress WD.
    J Biol Chem. 2012 Nov 23;287(48):40106-18. | Pubmed
  14. Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines
    Rettew AN, Young ED, Lev DC, Kleinerman ES, Abdul-Karim FW, Getty PJ, Greenfield EM
    Oncogenesis. 2012 November; 1(11): e34. Link
  15. A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature.
    Russo N, Wang X, Liu M, Banerjee R, Goto M, Scanlon C, Metwally T, Inglehart RC, Tsodikov A, Duffy S, Van Tubergen E, Bradford C, Carey T, Wolf G, Chinnaiyan AM, D'Silva NJ.
    Oncogene. 2012 Nov 19. | Pubmed
  16. β-Catenin activates the HOXA10 and CDX4 Genes in myeloid progenitor cells.
    Bei L, Shah C, Wang H, Huang W, Roy R, Eklund EA.
    J Biol Chem. 2012 Nov 16;287(47):39589-601. | Pubmed
  17. Differential network entropy reveals cancer system hallmarks.
    West J, Bianconi G, Severini S, Teschendorff AE.
    Sci Rep. 2012;2:802. | Pubmed
  18. A novel tumor suppressor network in squamous malignancies.
    Costa C, Santos M, Segrelles C, Dueñas M, Lara MF, Agirre X, Prosper F, García-Escudero R, Paramio JM.
    Sci Rep. 2012;2:828. | Pubmed
  19. RRM2B suppresses activation of the oxidative stress pathway and is up-regulated by P53 during senescence.
    Kuo ML, Sy AJ, Xue L, Chi M, -C Lee MT, Yen T, Chiang MI, Chang L, Chu P, Yen Y.
    Sci Rep. 2012;2:822. | Pubmed
  20. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.
    Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.
    PLoS One. 2012;7(11):e49462. | Pubmed
  21. Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation.
    Garufi A, Pistritto G, Ceci C, Di Renzo L, Santarelli R, Faggioni A, Cirone M, D'Orazi G.
    PLoS One. 2012;7(11):e48342. | Pubmed
  22. The enzymatic activity of apoptosis inducing factor supports energy metabolism benefitting the growth and invasiveness of advanced prostate cancer cells.
    Lewis EM, Wilkinson AS, Jackson JS, Mehra R, Varambally S, Chinnaiyan AM, Wilkinson JC.
    J Biol Chem. 2012 Nov 1. | Pubmed
  23. PNUTS functions as a proto-oncogene by sequestering PTEN.
    Kavela S, Shinde SR, Ratheesh R, Viswakalyan K, Bashyam MD, Gowrishankar S, Vamsy M, Pattnaik S, Rao S, Sastry RA, Srinivasulu M, Chen J, Maddika S.
    Cancer Res. 2012 Nov 1. | Pubmed
  24. Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients.
    Levacque Z, Rosales JL, Lee KY.
    Cell Cycle. 2012 Nov 1;11(21):4093-5. | Pubmed
  25. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
    Xu T, Qin R, Zhou J, Yan Y, Lu Y, Zhang X, Fu D, Lv Z, Li W, Xia C, Hu G, Ding X, Chen J.
    PLoS One. 2012;7(10):e48415. | Pubmed
  26. New insights into the role of Runx1 in epithelial stem cell biology and pathology.
    Scheitz CJ, Tumbar T.
    J Cell Biochem. 2012 Nov 13. | Pubmed
  27. Estrogen receptor prevents p53-dependent apoptosis in breast cancer.
    Bailey ST, Shin H, Westerling T, Liu XS, Brown M.
    Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18060-5. | Pubmed
  28. STEAP1 is overexpressed in cancers: A promising therapeutic target.
    Moreaux J, Kassambara A, Hose D, Klein B.
    Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):148-55. | Pubmed
  29. The experimental renal cell carcinoma model in the chick embryo.
    Fergelot P, Bernhard JC, Soulet F, Kilarski WW, Léon C, Courtois N, Deminière C, Herbert JM, Antczak P, Falciani F, Rioux-Leclercq N, Patard JJ, Ferrière JM, Ravaud A, Hagedorn M, Bikfalvi A.
    Angiogenesis. 2012 Oct 18. | Pubmed
  30. Osteoprotegerin in bone metastases: mathematical solution to the puzzle.
    Ryser MD, Qu Y, Komarova SV.
    PLoS Comput Biol. 2012 Oct;8(10):eFFFFF03. | Pubmed
  31. Mammalian sterile 20-like kinase 1 suppresses lymphoma development by promoting faithful chromosome segregation.
    Kim TS, Lee DH, Kim SK, Shin SY, Seo EJ, Lim DS.
    Cancer Res. 2012 Oct 15;72(20):5386-95. | Pubmed
  32. The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.
    Privette Vinnedge LM, Ho SM, Wikenheiser-Brokamp KA, Wells SI.
    PLoS One. 2012;7(10):e46985. | Pubmed
  33. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by blimp-1-dependent repression of BMP-5.
    Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE.
    Cancer Res. 2012 Dec 1;72(23):6268-6278. | Pubmed
  34. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
    Qin J, Wu SP, Creighton CJ, Dai F, Xie X, Cheng CM, Frolov A, Ayala G, Lin X, Feng XH, Ittmann MM, Tsai SJ, Tsai MJ, Tsai SY.
    Nature. 2012 Nov 28. | Pubmed
  35. CDX2 is an amplified lineage-survival oncogene in colorectal cancer.
    Salari K, Spulak ME, Cuff J, Forster AD, Giacomini CP, Huang S, Ko ME, Lin AY, van de Rijn M, Pollack JR.
    Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3196-205. | Pubmed
  36. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis.
    Reticker-Flynn NE, Malta DF, Winslow MM, Lamar JM, Xu MJ, Underhill GH, Hynes RO, Jacks TE, Bhatia SN.
    Nat Commun. 2012;3:1122. | Pubmed
  37. IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer.
    Baird AM, Leonard J, Naicker KM, Kilmartin L, O'Byrne KJ, Gray SG.
    Lung Cancer. 2012 Oct 29. pii: S0169-5002(12)00578-8. | Pubmed
  38. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.
    Luo W, Chang R, Zhong J, Pandey A, Semenza GL.
    Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):E3367-76. | Pubmed
  39. Prediction of core cancer genes using multi-task classification framework.
    Gao S, Xu S, Fang Y, Fang J.
    J Theor Biol. 2012 Oct 3;317C:62-70. | Pubmed
  40. GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer.
    Liu M, Wang G, Gomez-Fernandez CR, Guo S.
    PLoS One. 2012;7(10):e46410. | Pubmed
  41. Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.
    Scheitz CJ, Lee TS, McDermitt DJ, Tumbar T.
    EMBO J. 2012 Nov 5;31(21):4124-39. | Pubmed
  42. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
    Citterio C, Menacho-Márquez M, García-Escudero R, Larive RM, Barreiro O, Sánchez-Madrid F, Paramio JM, Bustelo XR.
    Sci Signal. 2012 Oct 2;5(244):ra71. | Pubmed
  43. Opposite roles of furin and PC5A in N-cadherin processing.
    Maret D, Sadr MS, Sadr ES, Colman DR, Del Maestro RF, Seidah NG.
    Neoplasia. 2012 Oct;14(10):880-92. | Pubmed
  44. Multiple cancer testis antigens function to support tumor cell mitotic fidelity.
    Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW.
    Mol Cell Biol. 2012 Oct;32(20):4131-40. | Pubmed
  45. HDAC11 is a novel drug target in carcinomas.
    Deubzer HE, Schier MC, Oehme I, Lodrini M, Haendler B, Sommer A, Witt O.
    Int J Cancer. 2012 Oct 1. | Pubmed
  46. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
    Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, Mahmoodi M, Schmidt MK, Broeks A, Cornelissen S, Braaf LM, Muir KR, et.al.
    Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1783-91. | Pubmed
  47. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC, Ma L.
    Nat Med. 2012 Oct;18(10):1511-7. | Pubmed
  48. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
    Wanka C, Steinbach JP, Rieger J.
    J Biol Chem. 2012 Sep 28;287(40):33436-46. | Pubmed
  49. The leukemia-associated fusion protein MN1-TEL blocks TEL-specific recognition sequences.
    ter Haar WM, Meester-Smoor MA, van Wely KH, Schot CC, Janssen MJ, Geverts B, Bonten J, Grosveld GC, Houtsmuller AB, Zwarthoff EC.
    PLoS One. 2012;7(9):e46085. | Pubmed
  50. WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.
    Yang PT, Anastas JN, Toroni RA, Shinohara MM, Goodson JM, Bosserhoff AK, Chien AJ, Moon RT.
    EMBO Mol Med. 2012 Dec;4(12):1294-307. | Pubmed
  51. Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin.
    Landin Malt A, Cagliero J, Legent K, Silber J, Zider A, Flagiello D.
    PLoS One. 2012;7(9):e45498. | Pubmed
  52. Stathmin is dispensable for tumor onset in mice.
    D'Andrea S, Berton S, Segatto I, Fabris L, Canzonieri V, Colombatti A, Vecchione A, Belletti B, Baldassarre G.
    PLoS One. 2012;7(9):e45561. | Pubmed
  53. MSI1 overexpression in diffuse type of gastric cancer.
    Nikpour P, Emadi-Baygi M, Mohhamad-Hashem F, Maracy MR, Haghjooy-Javanmard S.
    Pathol Res Pract. 2012 Nov 16. pii: S0344-0338(12)00271-3. | Pubmed
  54. Detection of STAT2 in early stage of cervical premalignancy and in cervical cancer.
    Liang Z, Gao LH, Cao LJ, Feng DY, Cao Y, Luo QZ, Yu P, Li M.
    Asian Pac J Trop Med. 2012 Sep;5(9):738-42. | Pubmed
  55. Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity.
    Faraji F, Pang Y, Walker RC, Nieves Borges R, Yang L, Hunter KW.
    PLoS Genet. 2012 Sep;8(9):eFFFFF26. | Pubmed
  56. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
    San-Marina S, Han Y, Liu J, Minden MD.
    Biochim Biophys Acta. 2012 Nov;1819(11-12):1164-72. | Pubmed
  57. Rat Mcs1b Is Concordant to the Genome-Wide Association-Identified Breast Cancer Risk Locus at Human 5q11.2 and MIER3 is a Candidate Cancer Susceptibility Gene.
    Dendekker AD, Xu X, Vaughn MD, Puckett AH, Gardner LL, Lambring CJ, Deschenes L, Samuelson DJ.
    Cancer Res. 2012 Nov 15;72(22):6002-12. | Pubmed
  58. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
    Buraschi S, Neill T, Owens RT, Iniguez LA, Purkins G, Vadigepalli R, Evans B, Schaefer L, Peiper SC, Wang ZX, Iozzo RV.
    PLoS One. 2012;7(9):e45559. | Pubmed
  59. MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.
    Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs S.
    Oncogene. 2012 Sep 17. | Pubmed
  60. Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.
    Dyrskjøt L, Reinert T, Novoradovsky A, Zuiverloon TC, Beukers W, Zwarthoff E, Malats N, Real FX, Segersten U, Malmström PU, Knowles M, Hurst C, Sorge J, Borre M, Orntoft TF.
    Br J Cancer. 2012 Oct 9;107(8):1392-8. | Pubmed
  61. Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis.
    Ketchart W, Smith KM, Krupka T, Wittmann BM, Hu Y, Rayman PA, Doughman YQ, Albert JM, Bai X, Finke JH, Xu Y, Exner AA, Montano MM.
    Oncogene. 2012 Sep 10. | Pubmed
  62. RHBDD2: a 5-fluorouracil responsive gene overexpressed in the advanced stages of colorectal cancer.
    Lacunza E, Canzoneri R, Rabassa ME, Zwenger A, Segal-Eiras A, Croce MV, Abba MC.
    Tumour Biol. 2012 Dec;33(6):2393-9. | Pubmed
  63. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV, Cyr AR, Woodfield GW, Bogachek M, Spanheimer PM, Li T, Price DH, Domann FE, Weigel RJ.
    Oncogene. 2012 Sep 10. | Pubmed
  64. Multiple roles of COUP-TFII in cancer initiation and progression.
    Litchfield LM, Klinge CM.
    J Mol Endocrinol. 2012 Oct 10;49(3):R135-48. | Pubmed
  65. Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
    Zhang K, Wang M, Tamayo AT, Shacham S, Kauffman M, Lee J, Zhang L, Ou Z, Li C, Sun L, Ford RJ, Pham LV.
    Exp Hematol. 2012 Sep 14. pii: S0301-472X(12)00383-9. | Pubmed
  66. Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer.
    Kuscu C, Evensen N, Kim D, Hu YJ, Zucker S, Cao J.
    PLoS One. 2012;7(9):e44661. | Pubmed
  67. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis.
    Teh MT, Hutchison IL, Costea DE, Neppelberg E, Liavaag PG, Purdie K, Harwood C, Wan H, Odell EW, Hackshaw A, Waseem A.
    Int J Cancer. 2012 Oct 4. | Pubmed
  68. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.
    Pippa R, Espinosa L, Gundem G, García-Escudero R, Dominguez A, Orlando S, Gallastegui E, Saiz C, Besson A, Pujol MJ, López-Bigas N, Paramio JM, Bigas A, Bachs O.
    Oncogene. 2012 Sep 20;31(38):4207-20. | Pubmed
  69. p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO.
    Shibata Y, Oyama M, Kozuka-Hata H, Han X, Tanaka Y, Gohda J, Inoue J.
    Nat Commun. 2012;3:1061. | Pubmed
  70. PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks.
    Krietsch J, Caron MC, Gagné JP, Ethier C, Vignard J, Vincent M, Rouleau M, Hendzel MJ, Poirier GG, Masson JY.
    Nucleic Acids Res. 2012 Nov 1;40(20):FFFFF-301. | Pubmed
  71. Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradation.
    Zhang L, Zhou F, Li Y, Drabsch Y, Zhang J, van Dam H, ten Dijke P.
    J Biol Chem. 2012 Aug 31;287(36):30701-10. | Pubmed
  72. Urinary BTA: indicator of bladder cancer or of hematuria.
    Miyake M, Goodison S, Rizwani W, Ross S, Bart Grossman H, Rosser CJ.
    World J Urol. 2012 Dec;30(6):869-73. | Pubmed
  73. The essential role of giα2 in prostate cancer cell migration.
    Zhong M, Clarke S, Vo BT, Khan SA.
    Mol Cancer Res. 2012 Oct;10(10):1380-8. | Pubmed
  74. CD24 Is an Effector of HIF-1-Driven Primary Tumor Growth and Metastasis.
    Thomas S, Harding MA, Smith SC, Overdevest JB, Nitz MD, Frierson HF, Tomlins SA, Kristiansen G, Theodorescu D.
    Cancer Res. 2012 Nov 1;72(21):5600-12. | Pubmed
  75. Selective requirement for Mediator MED23 in Ras-active lung cancer.
    Yang X, Zhao M, Xia M, Liu Y, Yan J, Ji H, Wang G.
    Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2813-22. | Pubmed
  76. Regulation of Human RNase-L by the miR-29 Family Reveals a Novel Oncogenic Role in Chronic Myelogenous Leukemia.
    Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA.
    J Interferon Cytokine Res. 2012 Oct 31. | Pubmed
  77. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
    Lin ZS, Chu HC, Yen YC, Lewis BC, Chen YW.
    PLoS One. 2012;7(8):e43593. | Pubmed
  78. Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis.
    Zhou S, Liu R, Yuan K, Yi T, Zhao X, Huang C, Wei Y.
    Mass Spectrom Rev. 2012 Nov 19. | Pubmed
  79. 14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival.
    Murata T, Takayama K, Urano T, Fujimura T, Ashikari D, Obinata D, Horie-Inoue K, Takahashi S, Ouchi Y, Homma Y, Inoue S.
    Clin Cancer Res. 2012 Oct 15;18(20):5617-27. | Pubmed
  80. Multifunctional protein APPL2 contributes to survival of human glioma cells.
    Pyrzynska B, Banach-Orlowska M, Teperek-Tkacz M, Miekus K, Drabik G, Majka M, Miaczynska M.
    Mol Oncol. 2012 Sep 5. pii: S1574-7891(12)00082-8. | Pubmed
  81. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity.
    Zhen C, Chen L, Zhao Q, Liang B, Gu YX, Bai ZF, Wang K, Xu X, Han QY, Fang DF, Wang SX, Zhou T, Xia Q, Gong WL, Wang N, Li HY, Jin BF, Man JH.
    Oncogene. 2012 Aug 13. | Pubmed
  82. Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas.
    Kim HE, Kim DG, Lee KJ, Son JG, Song MY, Park YM, Kim JJ, Cho SW, Chi SG, Cheong HS, Shin HD, Lee SW, Lee JK.
    PLoS One. 2012;7(8):e43223. | Pubmed
  83. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis.
    Costa C, Santos M, Martínez-Fernández M, Dueñas M, Lorz C, García-Escudero R, Paramio JM.
    Oncogene. 2012 Aug 13. | Pubmed
  84. TCL1A and ATM are coexpressed in chronic lymphocytic leukemia cells without deletion of 11q.
    Garding A, Bhattacharya N, Haebe S, Mueller F, Weichenhan D, Idler I, Ickstadt K, Stilgenbauer S, Mertens D.
    Haematologica. 2012 Aug 8. | Pubmed
  85. Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes.
    Dueñas M, Santos M, Aranda JF, Bielza C, Martínez-Cruz AB, Lorz C, Taron M, Ciruelos EM, Rodríguez-Peralto JL, Martín M, Larrañaga P, Dahabreh J, Stathopoulos GP, Rosell R, Paramio JM, García-Escudero R.
    PLoS One. 2012;7(8):e42494. | Pubmed
  86. The emerging role of histone lysine demethylases in prostate cancer.
    Crea F, Sun L, Mai A, Chiang YT, Farrar WL, Danesi R, Helgason CD.
    Mol Cancer. 2012 Aug 6;11:52. | Pubmed
  87. Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer.
    Stevenson L, Allen WL, Turkington R, Jithesh PV, Proutski I, Stewart G, Lenz HJ, Van Schaeybroeck S, Longley DB, Johnston PG.
    Clin Cancer Res. 2012 Oct 1;18(19):5412-26. | Pubmed
  88. Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.
    Mulvihill MS, Kwon YW, Lee S, Fang LT, Choi H, Ray R, Kang HC, Mao JH, Jablons D, Kim IJ.
    PLoS One. 2012;7(8):e42264. | Pubmed
  89. Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.
    Kosa P, Szabo R, Molinolo AA, Bugge TH.
    Oncogene. 2012 Aug 9;31(32):3679-95. | Pubmed
  90. Targeting Jab1/CSN5 in nasopharyngeal carcinoma.
    Pan Y, Claret FX.
    Cancer Lett. 2012 Dec 30;326(2):155-60. | Pubmed
  91. Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms.
    McBrayer SK, Yarrington M, Qian J, Feng G, Shanmugam M, Gandhi V, Krett NL, Rosen ST.
    PLoS One. 2012;7(7):e41455. | Pubmed
  92. FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression.
    Wang T, Pei X, Zhan J, Hu J, Yu Y, Zhang H.
    FEBS Lett. 2012 Sep 21;586(19):3044-50. | Pubmed
  93. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis.
    Lee EW, Kim JH, Ahn YH, Seo J, Ko A, Jeong M, Kim SJ, Ro JY, Park KM, Lee HW, Park EJ, Chun KH, Song J.
    Nat Commun. 2012;3:978. | Pubmed
  94. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
    Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.
    Urol Oncol. 2012 Aug 31. | Pubmed
  95. Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells.
    Claerhout S, Dutta B, Bossuyt W, Zhang F, Nguyen-Charles C, Dennison JB, Yu Q, Yu S, Balázsi G, Lu Y, Mills GB.
    PLoS One. 2012;7(6):e39400. | Pubmed
  96. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
    Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, de la Serna I, Yeung KC.
    Cancer Res. 2012 Jun 15;72(12):3091-104. | Pubmed
  97. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer
    Pankaj Sharma, Swathi Chinaranagari, Divya Patel, Jason Carey, Jaideep Chaudhary
    Cancer Medicine Volume 1, Issue 2, pages 176–186, October 2012 Link
  98. HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma.
    Nguyen Kovochich A, Arensman M, Lay AR, Rao NP, Donahue T, Li X, French SW, Dawson DW.
    Cancer. 2012 Aug 22. | Pubmed
  99. Anterior Gradient 2 Overexpression in Lung Adenocarcinoma
    Pizzi M, Fassan M, Balistreri M, Galligioni A, Rea F, Rugge M.
    Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):31-6. | Pubmed
  100. Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs
    Geutjes EJ, Tian S, Roepman P, Bernards R.
    Breast Cancer Res Treat. 2012 Feb;131(3):809-18. | Pubmed
  101. Potential role of acid sphingomyelinase in environmental health.
    He X, Schuchman EH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Feb;37(2):109-25. | Pubmed
  102. Loss of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) induces apoptotic processes in pancreatic carcinoma cells
    Kemmner W, Kessel P, Sanchez-Ruderisch H, Möller H, Hinderlich S, Schlag PM, Detjen K.
    FASEB J. 2012 Feb;26(2):938-46. | Pubmed
  103. Recent advances in metabolomics in oncology
    O'Connell TM.
    Bioanalysis. 2012 Feb;4(4):431-51. | Pubmed
  104. Unique DNA methylome profiles in CpG island methylator phenotype colon cancers
    Xu Y, Hu B, Choi AJ, Gopalan B, Lee BH, Kalady MF, Church JM, Ting AH.
    Genome Res. 2012 Feb;22(2):283-91. | Pubmed
  105. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
    Okabe H, Beppu T, Ueda M, Hayashi H, Ishiko T, Masuda T, Otao R, Horlad H, Mima K, Miyake K, Iwatsuki M, Baba Y, Takamori H, Jono H, Shinriki S, Ando Y, Baba H.
    Int J Cancer. 2012 Feb 15. | Pubmed
  106. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.
    Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SP
    PLoS One. 2012;7(2):e31507. | Pubmed
  107. Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses
    Jiang W, Chen X, Liao M, Li W, Lian B, Wang L, Meng F, Liu X, Chen X, Jin Y, Li X.
    Sci Rep. 2012;2:282. | Pubmed
  108. Antiangiogenic Effects and Therapeutic Targets of Azadirachta indica Leaf Extract in Endothelial Cells
    Mahapatra S, Young CY, Kohli M, Karnes RJ, Klee EW, Holmes MW, Tindall DJ, Donkena KV.
    Evid Based Complement Alternat Med. 2012;2012:303019. | Pubmed
  109. Sirtuins, metabolism, and cancer.
    Martinez-Pastor B, Mostoslavsky R.
    Front Pharmacol. 2012;3:22. | Pubmed
  110. Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint control.
    Thanasopoulou A, Stravopodis DJ, Dimas KS, Schwaller J, Anastasiadou E.
    PLoS One. 2012;7(2):e31007. | Pubmed
  111. Netrin-4 promotes glioblastoma cell proliferation through integrin β4 signaling.
    Hu Y, Ylivinkka I, Chen P, Li L, Hautaniemi S, Nyman TA, Keski-Oja J, Hyytiäinen M.
    Neoplasia. 2012 Mar;14(3):219-27. | Pubmed
  112. Role of ERRF, a Novel ER-Related Nuclear Factor, in the Growth Control of ER-Positive Human Breast Cancer Cells
    Su, Dan; Fu, Xiaoying; Fan, Songqing; Wu, Xiao; Wang, Xin-Xin; Fu, Liya; Dong, Xue-Yuan; Ni, Jianping Jenny; Fu, Li; Zhu, Zhengmao; Dong, Jin-Tang
    Am J Pathol. 2012 Mar;180(3):1189-201. | Pubmed
  113. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.
    Ding Z, Wu CJ, Jaskelioff M, Ivanova E, Kost-Alimova M, Protopopov A, Chu GC, Wang G, Lu X, Labrot ES, Hu J, Wang W, Xiao Y, Zhang H, Zhang J, Zhang J, Gan B, Perry SR, Jiang S, Li L, Horner JW, Wang YA, Chin L, DePinho RA.
    Cell. 2012 Mar 2;148(5):896-907. | Pubmed
  114. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.
    van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA, Griffioen AW.
    Oncogene. 2012 Mar 5. | Pubmed
  115. An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation.
    López-Contreras AJ, Gutierrez-Martinez P, Specks J, Rodrigo-Perez S, Fernandez-Capetillo O.
    J Exp Med. 2012 Mar 12;209(3):455-61. | Pubmed
  116. Endothelial Expression of TNF Receptor-1 Generates a Proapoptotic Signal Inhibited by Integrin alpha 6 beta 1 in Glioblastoma
    Huang, Ping; Rani, M. R. Sandhya; Ahluwalia, Manmeet S.; Bae, Eunnyung; Prayson, Richard A.; Weil, Robert J.; Nowacki, Amy S.; Hedayat, Hirad; Sloan, Andrew E.; Lathia, Justin D.; Rich, Jeremy N.; Tibbs, Russell; Gladson, Candece L.
    Cancer Res. 2012 Mar 15;72(6):1428-37. | Pubmed
  117. Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.
    Yu Z, Sato S, Trackman PC, Kirsch KH, Sonenshein GE.
    PLoS One. 2012;7(3):e33287. | Pubmed
  118. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml.
    Lucarelli G, Fanelli M, Larocca AM, Germinario CA, Rutigliano M, Vavallo A, Selvaggi FP, Bettocchi C, Battaglia M, Ditonno P.
    Prostate. 2012 Mar 16. | Pubmed
  119. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
    Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R, Heguy A, Viale A, Morris LG, Huse JT, Mellinghoff IK, Chan TA.
    Nature. 2012 Feb 15;483(7390):479-83. | Pubmed
  120. Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma.
    Poh W, Wong W, Ong H, Aung MO, Lim SG, Chua BT, Ho HK.
    Mol Cancer. 2012 Mar 23;11:14. | Pubmed
  121. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
    Saito R, Shirakawa R, Nishiyama H, Kobayashi T, Kawato M, Kanno T, Nishizawa K, Matsui Y, Ohbayashi T, Horiguchi M, Nakamura T, Ikeda T, Yamane K, Nakayama E, Nakamura E, Toda Y, Kimura T, Kita T, Ogawa O, Horiuchi H.
    Oncogene. 2012 Mar 26. | Pubmed
  122. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation
    Xing C, Xie H, Zhou L, Zhou W, Zhang W, Ding S, Wei B, Yu X, Su R, Zheng S.
    Biochem Biophys Res Commun. 2012 Mar 30;420(1):29-35. | Pubmed
  123. Androglobin: A Chimeric Globin in Metazoans That Is Preferentially Expressed in Mammalian Testes
    Hoogewijs D, Ebner B, Germani F, Hoffmann FG, Fabrizius A, Moens L, Burmester T, Dewilde S, Storz JF, Vinogradov SN, Hankeln T.
    Mol Biol Evol. 2012 Apr;29(4):1105-14. | Pubmed
  124. Human Mut T Homolog 1 (MTH1): A roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS.
    Rai P.
    Small GTPases. 2012 Apr 1;3(2):120-5. | Pubmed
  125. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S, Shiraha H, Nakanishi Y, Nishina SI, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K.
    Int J Cancer. 2012 Apr 5. | Pubmed
  126. Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.
    Jeong WJ, Yoon J, Park JC, Lee SH, Lee SH, Kaduwal S, Kim H, Yoon JB, Choi KY.
    Sci Signal. 2012 Apr 10;5(219):ra30. | Pubmed
  127. TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo
    Spranger S, Jeremias I, Wilde S, Leisegang M, Stärck L, Mosetter B, Uckert W, Heemskerk MH, Schendel DJ, Frankenberger B.
    Blood. 2012 Apr 12;119(15):3440-9. | Pubmed
  128. Overexpression of s6 kinase 1 in brain tumours is associated with induction of hypoxia-responsive genes and predicts patients' survival.
    Ismail HM.
    J Oncol. 2012;2012:416927. | Pubmed
  129. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells.
    Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y, Ciceri F, Blaser JG, Greystoke BF, Jordan AM, Miller CJ, Ogilvie DJ, Somervaille TC.
    Cancer Cell. 2012 Apr 17;21(4):473-87. | Pubmed
  130. Analysis of micrornas by neural network for early detection of cancer
    Adali T, Sekeroglu B
    Procedia Technology Link
  131. Experimental Verification of a Predicted Intronic MicroRNA in Human NGFR Gene with a Potential Pro-Apoptotic Function
    Parsi S, Soltani BM, Hosseini E, Tousi SE, Mowla SJ.
    PLoS One. 2012;7(4):e35561. | Pubmed
  132. Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.
    Ren K, Lu J, Porollo A, Du C.
    J Biol Chem. 2012 Apr 27;287(18):14792-802. | Pubmed
  133. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity
    Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK.
    Oncogene. 2012 Apr 30. | Pubmed
  134. New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients
    Bou Samra E, Moreaux J, Vacheret F, Mills K, Rufflé F, Chiesa J, Piquemal D, Boureux A, Lavabre-Bertrand T, Jourdan E, Commes T.
    Br J Haematol. 2012 May;157(3):347-56. | Pubmed
  135. G alpha 12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis
    Boucher I, Yu W, Beaudry S, Negoro H, Tran M, Pollak MR, Henderson JM, Denker BM.
    Lab Invest. 2012 May;92(5):662-75. | Pubmed
  136. Defining NOTCH3 target genes in ovarian cancer.
    Chen X, Thiaville MM, Chen L, Stoeck A, Xuan J, Gao M, Shih IeM, Wang TL.
    Cancer Res. 2012 May 1;72(9):2294-303. | Pubmed
  137. An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
    Crea, F.; Fornaro, L.; Paolicchi, E.; Masi, G.; Frumento, P.; Loupakis, F.; Salvatore, L.; Cremolini, C.; Schirripa, M.; Graziano, F.; Ronzoni, M.; Ricci, V.; Farrar, W. L.; Falcone, A.; Danesi, R.
    Ann Oncol. 2012 May;23(5):1207-13. | Pubmed
  138. Overexpression of Kinesin Associated Protein 3 (KIFAP3) in Breast Cancer
    Telikicherla D, Maharudraiah J, Pawar H, Marimuthu A, Kashyap MK, Ramachandra YL, Roa JC, Pandey A
    Journal of Proteomics & Bioinformatics Link
  139. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.
    Pazolli E, Alspach E, Milczarek A, Prior J, Piwnica-Worms D, Stewart SA.
    Cancer Res. 2012 May 1;72(9):2251-61. | Pubmed
  140. Cyr61 is a potential prognostic marker for prostate cancer
    Terada, Naoki; Kulkarni, Prakash; Getzenberg, Robert H.
    Asian J Androl. 2012 May;14(3):405-8. | Pubmed
  141. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
    Wang CA, Jedlicka P, Patrick AN, Micalizzi DS, Lemmer KC, Deitsch E, Casás-Selves M, Harrell JC, Ford HL.
    J Clin Invest. 2012 May 1;122(5):1895-906. | Pubmed
  142. Allelic Variation and Differential Expression of the mSIN3A Histone Deacetylase Complex Gene Arid4b Promote Mammary Tumor Growth and Metastasis.
    Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW.
    PLoS Genet. 2012 May;8(5):eFFFFF35. | Pubmed
  143. Mechanisms of apoptosis by the tumor suppressor Par-4
    Hebbar N, Wang C, Rangnekar VM.
    J Cell Physiol. 2012 May 2. | Pubmed
  144. Identification of PBX1 Target Genes in Cancer Cells by Global Mapping of PBX1 Binding Sites
    Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Magnani, Luca; Oidtman, Jessica; Shih, Ie-Ming; Lupien, Mathieu; Wang, Tian-Li
    PLoS One. 2012;7(5):e36054. | Pubmed
  145. DR6 as a Diagnostic and Predictive Biomarker in Adult Sarcoma
    Yang K, Mooney C, Spahlinger G, Schuetze S, Arias-Pulido H, Verschraegen C, Gimotty P, Buckanovich RJ.
    PLoS One. 2012;7(5):e36525. | Pubmed
  146. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
    Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG.
    Cell Stem Cell. 2012 May 4;10(5):556-69. | Pubmed
  147. TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.
    Chio II, Sasaki M, Ghazarian D, Moreno J, Done S, Ueda T, Inoue S, Chang YL, Chen NJ, Mak TW.
    Nat Cell Biol. 2012 May 6;14(6):625-33. | Pubmed
  148. Regulation of Integrin Endocytic Recycling and Chemotactic Cell Migration by Syntaxin 6 and VAMP3 Interaction.
    Riggs KA, Hasan N, Humphrey D, Raleigh C, Nevitt C, Corbin D, Hu C.
    J Cell Sci. 2012 May 8. | Pubmed
  149. MGEx-Udb: A Mammalian Uterus Database for Expression-Based Cataloguing of Genes across Conditions, Including Endometriosis and Cervical Cancer
    Bajpai, Akhilesh K.; Davuluri, Sravanthi; Chandrashekar, Darshan S.; Ilakya, Selvarajan; Dinakaran, Mahalakshmi; Acharya, Kshitish K.
    PLoS One. 2012;7(5):e36776. | Pubmed
  150. Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes.
    Akhavan A, Griffith OL, Soroceanu L, Leonoudakis D, Luciani-Torres MG, Daemen A, Gray JW, Muschler JL.
    Cancer Res. 2012 May 15;72(10):2578-88. | Pubmed
  151. DNA methylation screening identifies driver epigenetic events of cancer cell survival.
    De Carvalho DD, Sharma S, You JS, Su SF, Taberlay PC, Kelly TK, Yang X, Liang G, Jones PA.
    Cancer Cell. 2012 May 15;21(5):655-67. | Pubmed
  152. KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.
    Kelber JA, Reno T, Kaushal S, Metildi C, Wright T, Stoletov K, Weems JM, Park FD, Mose E, Wang Y, Hoffman RM, Lowy AM, Bouvet M, Klemke RL.
    Cancer Res. 2012 May 15;72(10):2554-64. | Pubmed
  153. ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration
    Obinata, Daisuke; Takayama, Ken-ichi; Urano, Tomohiko; Murata, Taro; Ikeda, Kazuhiro; Horie-Inoue, Kuniko; Ouchi, Yasuyoshi; Takahashi, Satoru; Inoue, Satoshi
    Int J Cancer. 2012 May 15;130(10):2240-8. link| Pubmed
  154. GAS2L3, a target gene of the DREAM complex, is required for proper cytokinesis and genomic stability.
    Wolter P, Schmitt K, Fackler M, Kremling H, Probst L, Hauser S, Gruss OJ, Gaubatz S.
    J Cell Sci. 2012 May 15;125(Pt 10):2393-406. | Pubmed
  155. Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.
    McBrayer SK, Cheng JC, Singhal S, Krett NL, Rosen ST, Shanmugam M.
    Blood. 2012 May 17;119(20):4686-97. | Pubmed
  156. Cks1 Is Required for Tumor Cell Proliferation but Not Sufficient to Induce Hematopoietic Malignancies
    Kratzat S, Nikolova V, Miething C, Hoellein A, Schoeffmann S, Gorka O, Pietschmann E, Illert AL, Ruland J, Peschel C, Nilsson J, Duyster J, Keller U.
    PLoS One. 2012;7(5):e37433. | Pubmed
  157. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.
    Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, Revill K, Weissmueller S, Rappaport AR, Simon J, Zhang J, Luo W, Hicks J, Zender L, Wang XW, Powers S, Wigler M, Lowe SW.
    Proc Natl Acad Sci U S A. 2012 May 22;109(21):8212-7. | Pubmed
  158. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
    Montgomery N, Hill A, McFarlane S, Neisen J, O'Grady A, Conlon S, Jirstrom K, Kay EW, Waugh DJ.
    Breast Cancer Res. 2012 May 23;14(3):R84. | Pubmed
  159. Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis.
    Tran PT, Shroff EH, Burns TF, Thiyagarajan S, Das ST, Zabuawala T, Chen J, Cho YJ, Luong R, Tamayo P, Salih T, Aziz K, Adam SJ, Vicent S, Nielsen CH, Withofs N, Sweet-Cordero A, Gambhir SS, Rudin CM, Felsher DW.
    PLoS Genet. 2012 May;8(5):eFFFFF50. | Pubmed
  160. A Methodological Approach to Unravel Organ-Specific Breast Cancer Metastasis.
    Nola S, Sin S, Bonin F, Lidereau R, Driouch K.
    J Mammary Gland Biol Neoplasia. 2012 May 25. | Pubmed
  161. TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.
    Weng J, Rawal S, Chu F, Park HJ, Sharma R, Delgado DA, Fayad L, Fanale M, Romaguera J, Luong A, Kwak LW, Neelapu SS.
    Blood. 2012 May 29. | Pubmed
  162. Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor β Transcription in Breast Cancer Cells.
    Litchfield LM, Riggs KA, Hockenberry AM, Oliver LD, Barnhart KG, Cai J, Pierce WM Jr, Ivanova MM, Bates PJ, Appana SN, Datta S, Kulesza P, McBryan J, Young LS, Klinge CM.
    PLoS One. 2012;7(5):e38278. | Pubmed
  163. Conserved Expression Signatures between Medaka and Human Pigment Cell Tumors.
    Schartl M, Kneitz S, Wilde B, Wagner T, Henkel CV, Spaink HP, Meierjohann S.
    PLoS One. 2012;7(5):e37880. | Pubmed
  164. RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation.
    Cho HS, Hayami S, Toyokawa G, Maejima K, Yamane Y, Suzuki T, Dohmae N, Kogure M, Kang D, Neal DE, Ponder BA, Yamaue H, Nakamura Y, Hamamoto R.
    Neoplasia. 2012 Jun;14(6):476-86. | Pubmed
  165. Epithelial immune cell-like transition (EIT): a proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers.
    Choi SY, Gout PW, Collins CC, Wang Y.
    Differentiation. 2012 Jun;83(5):293-8. | Pubmed
  166. Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target.
    Gerlinger M, Santos CR, Spencer-Dene B, Martinez P, Endesfelder D, Burrell RA, Vetter M, Jiang M, Saunders RE, Kelly G, Dykema K, Rioux-Leclercq N, Stamp G, Patard JJ, Larkin J, Howell M, Swanton C.
    J Pathol. 2012 Jun;227(2):146-56. | Pubmed
  167. Losing balance: the origin and impact of aneuploidy in cancer
    Holland, Andrew J.; Cleveland, Don W.
    EMBO Rep. 2012 Jun 1;13(6):501-14. | Pubmed
  168. Digital gene expression profiling of primary acute lymphoblastic leukemia cells
    Nordlund, J.; Kiialainen, A.; Karlberg, O.; Berglund, E. C.; Goransson-Kultima, H.; Sonderkaer, M.; Nielsen, K. L.; Gustafsson, M. G.; Behrendtz, M.; Forestier, E.; Perkkio, M.; Soderhall, S.; Lonnerholm, G.; Syvanen, A-C
    Leukemia. 2012 Jun;26(6):1218-27. | Pubmed
  169. Human nuclease/helicase DNA2 alleviates replication stress by promoting DNA end resection.
    Peng G, Dai H, Zhang W, Hsieh HJ, Pan MR, Park YY, Tsai RY, Bedrosian I, Lee JS, Ira G, Lin SY.
    Cancer Res. 2012 Jun 1;72(11):2802-13. | Pubmed
  170. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
    Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R.
    Cancer Metastasis Rev. 2012 Jun;31(1-2):295-321. | Pubmed
  171. NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape
    Mori, Tsutomu; Ikeda, Daisuke D.; Yamaguchi, Yoshiki; Unoki, Motoko
    FEBS Lett. 2012 Jun 4;586(11):1570-83. | Pubmed
  172. Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.
    Ragusa M, Statello L, Maugeri M, Majorana A, Barbagallo D, Salito L, Sammito M, Santonocito M, Angelica R, Cavallaro A, Scalia M, Caltabiano R, Privitera G, Biondi A, Di Vita M, Cappellani A, Vasquez E, Lanzafame S, Tendi E, Celeste S, Di Pietro C, Basile F, Purrello M.
    J Mol Med (Berl). 2012 Jun 4. | Pubmed
  173. Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers.
    Laffin B, Petrash JM.
    Front Pharmacol. 2012;3:104. | Pubmed
  174. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
    Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY, Bach RR, Rak J, Church FC, Wolberg AS, Pawlinski R, Key NS, Yeh JJ, Mackman N.
    Blood. 2012 Jun 7;119(23):5543-52 | Pubmed
  175. Hepatoma Cells From Mice Deficient in Glycine N-Methyltransferase Have Increased RAS Signaling and Activation of Liver Kinase B1.
    Martínez-López N, García-Rodríguez JL, Varela-Rey M, Gutiérrez V, Fernández-Ramos D, Beraza N, Aransay AM, Schlangen K, Lozano JJ, Aspichueta P, Luka Z, Wagner C, Evert M, Calvisi DF, Lu SC, Mato JM, Martínez-Chantar ML.
    Gastroenterology. 2012 Jun 8. | Pubmed
  176. Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.
    Gelman IH.
    Cancer Metastasis Rev. 2012 Jun 9. | Pubmed
  177. NuMA Overexpression in Epithelial Ovarian Cancer.
    Brüning-Richardson A, Bond J, Alsiary R, Richardson J, Cairns DA, McCormac L, Hutson R, Burns PA, Wilkinson N, Hall GD, Morrison EE, Bell SM.
    PLoS One. 2012;7(6):e38945. | Pubmed
  178. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
    Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA.
    Breast Cancer Res. 2012 Jun 14;14(3):R95. | Pubmed
  179. The RNA processing and modification protein, carbon catabolite repression 4, arrests the cell cycle through a p21-dependent and p53-independent pathway
    Yi X, Hong M, Gui B, Chen Z, Li L, Xie G, Liang J, Wang X, Shang Y.
    J Biol Chem. 2012 Jun 15;287(25):21045-57. | Pubmed
  180. Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer.
    Telikicherla D, Marimuthu A, Kashyap MK, Y L R, Mohan S, Roa JC, Maharudraiah J, Pandey A.
    Clin Proteomics. 2012 Jun 18;9(1):7. | Pubmed
  181. EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.
    Crea F, Fornaro L, Bocci G, Sun L, Farrar WL, Falcone A, Danesi R.
    Cancer Metastasis Rev. 2012 Jun 19. | Pubmed
  182. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.
    García-Bernal D, Redondo-Muñoz J, Dios-Esponera A, Chèvre R, Bailón E, Garayoa M, Arellano-Sánchez N, Gutierrez NC, Hidalgo A, García-Pardo A, Teixidó J.
    J Pathol. 2012 Jun 19. | Pubmed
  183. Fas-associated factor 1 is a scaffold protein that promotes β-TrCP mediated β-catenin ubiquitination and degradation
    Zhang L, Zhou F, Li Y, Drabsch Y, Zhang J, van Dam H, Ten Dijke P.
    J Biol Chem. 2012 Jun 22. | Pubmed
  184. ZRF1 controls oncogene-induced senescence through the INK4-ARF locus.
    Ribeiro JD, Morey L, Mas A, Gutierrez A, Luis NM, Mejetta S, Richly H, Benitah SA, Keyes WM, Di Croce L.
    Oncogene. 2012 Jun 25. | Pubmed
  185. Abortive Autophagy Induces Endoplasmic Reticulum Stress and Cell Death in Cancer Cells
    Claerhout S, Dutta B, Bossuyt W, Zhang F, Nguyen-Charles C, Dennison JB, Yu Q, Yu S, Balázsi G, Lu Y, Mills GB.
    PLoS One. 2012;7(6):e39400. | Pubmed
  186. Identification of Kinases Regulating Prostate Cancer Cell Growth Using an RNAi Phenotypic Screen.
    Whitworth H, Bhadel S, Ivey M, Conaway M, Spencer A, Hernan R, Holemon H, Gioeli D.
    PLoS One. 2012;7(6):e38950. | Pubmed
  187. Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling.
    Akakura S, Gelman IH.
    J Signal Transduct. 2012;2012:529179. | Pubmed
  188. FoxM1 Regulates Mammary Luminal Cell Fate.
    Carr JR, Kiefer MM, Park HJ, Li J, Wang Z, Fontanarosa J, Dewaal D, Kopanja D, Benevolenskaya EV, Guzman G, Raychaudhuri P.
    Cell Rep. 2012 Jun 28;1(6):715-29. | Pubmed
  189. Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients.
    Greither T, Koser F, Kappler M, Bache M, Lautenschläger C, Göbel S, Holzhausen HJ, Wach S, Würl P, Taubert H.
    BMC Cancer. 2012 Jun 29;12(1):272. | Pubmed
  190. The atypical histone macroH2A1.2 interacts with HER-2 in cancer cells.
    Li X, Kuang J, Shen Y, Majer MM, Nelson CC, Parsawar K, Heichman KA, Kuwada SK.
    J Biol Chem. 2012 Jun 29;287(27):23171-83. | Pubmed
  191. A Humanized Mouse Model of HPV-Associated Pathology Driven by E7 Expression
    Buitrago-Pérez A
    PLoS ONE Link
  192. KDM3B Is the H3K9 Demethylase Involved in Transcriptional Activation of lmo2 in Leukemia.
    Kim JY, Kim KB, Eom GH, Choe N, Kee HJ, Son HJ, Oh ST, Kim DW, Pak JH, Baek HJ, Kook H, Hahn Y, Kook H, Chakravarti D, Seo SB.
    Mol Cell Biol. 2012 Jul;32(14):2917-33. | Pubmed
  193. Genome-wide profiles of H2AX and γ-H2AX differentiate endogenous and exogenous DNA damage hotspots in human cells.
    Seo J, Kim SC, Lee HS, Kim JK, Shon HJ, Salleh NL, Desai KV, Lee JH, Kang ES, Kim JS, Choi JK.
    Nucleic Acids Res. 2012 Jul 1;40(13):5965-5974. | Pubmed
  194. The role of epigenetic regulation in stem cell and cancer biology.
    van Vlerken LE, Hurt EM, Hollingsworth RE.
    J Mol Med (Berl). 2012 Jul;90(7):791-801. | Pubmed
  195. SGK3 is associated with estrogen receptor expression in breast cancer.
    Xu J, Wan M, He Q, Bassett RL Jr, Fu X, Chen AC, Shi F, Creighton CJ, Schiff R, Huo L, Liu D.
    Breast Cancer Res Treat. 2012 Jul;134(2):531-41. | Pubmed
  196. Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.
    Yang M, Kozminski DJ, Wold LA, Modak R, Calhoun JD, Isom LL, Brackenbury WJ.
    Breast Cancer Res Treat. 2012 Jul;134(2):603-15. | Pubmed
  197. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
    Kent OA, Fox-Talbot K, Halushka MK.
    Oncogene. 2012 Jul 2. | Pubmed
  198. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells
    Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C.
    J Biol Chem. 2012 Jul 2. | Pubmed
  199. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.
    Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen K, Struhl K, Garcia BA, Gozani O, Li W, Chua KF.
    Nature. 2012 Jul 5;487(7405):114-8. | Pubmed
  200. Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells
    Feng L, Pan M, Sun J, Lu H, Shen Q, Zhang S, Jiang T, Liu L, Jin W, Chen Y, Wang X, Jin H.
    J Mol Med (Berl). 2012 Jul 5. | Pubmed
  201. Ei24-deficiency attenuates protein kinase Cα signaling and skin carcinogenesis in mice.
    Devkota S, Sung YH, Choi JM, Lee J, Ha NY, Kim H, Cho BC, Song J, Lee HW.
    Int J Biochem Cell Biol. 2012 Jul 6;44(11):1887-1896. | Pubmed
  202. p85β phosphoinositide 3-kinase subunit regulates tumor progression.
    Cortés I, Sánchez-Ruíz J, Zuluaga S, Calvanese V, Marqués M, Hernández C, Rivera T, Kremer L, González-García A, Carrera AC.
    Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11318-23. | Pubmed
  203. The Forkhead Box Transcription Factor FOXC1 Promotes Breast Cancer Invasion by Inducing Matrix Metalloprotease 7 (MMP7) Expression.
    Sizemore ST, Keri RA.
    J Biol Chem. 2012 Jul 13;287(29):24631-40. | Pubmed
  204. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer
    Smith SC, Baras AS, Owens CR, Dancik G, Theodorescu D.
    Cancer Res. 2012 Jul 15;72(14):3480-91. | Pubmed
  205. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
    Ezponda T, Popovic R, Shah MY, Martinez-Garcia E, Zheng Y, Min DJ, Will C, Neri A, Kelleher NL, Yu J, Licht JD.
    Oncogene. 2012 Jul 16. | Pubmed
  206. Synaptotagmin-like proteins control the formation of a single apical membrane domain in epithelial cells.
    Gálvez-Santisteban M, Rodriguez-Fraticelli AE, Bryant DM, Vergarajauregui S, Yasuda T, Bañón-Rodríguez I, Bernascone I, Datta A, Spivak N, Young K, Slim CL, Brakeman PR, Fukuda M, Mostov KE, Martín-Belmonte F.
    Nat Cell Biol. 2012 Jul 22;14(8):838-49. | Pubmed
  207. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances
    Muller P, Ruckova E, Halada P, Coates PJ, Hrstka R, Lane DP, Vojtesek B.
    Oncogene. 2012 Jul 23. | Pubmed
  208. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
    Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, Smas ME, Winokur D, Gilman AJ, Ulman MJ, Xega K, Contino G, Alagesan B, Brannigan BW, Milos PM, Ryan DP, Sequist LV, Bardeesy N, Ramaswamy S, Toner M, Maheswaran S, Haber DA.
    Nature. 2012 Jul 26;487(7408):510-3. | Pubmed
  209. MAP17 and the double-edged sword of ROS
    Carnero A
    Biochim Biophys Acta. 2012 Aug;1826(1):44-52. | Pubmed
  210. Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.
    Diaz J, Aranda E, Henriquez S, Quezada M, Espinoza E, Bravo ML, Oliva B, Lange S, Villalon M, Jones M, Brosens JJ, Kato S, Cuello MA, Knutson TP, Lange CA, Leyton L, Owen GI.
    J Endocrinol. 2012 Aug;214(2):165-175. | Pubmed
  211. Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling.
    Hu B, Nandhu MS, Sim H, Agudelo-Garcia PA, Saldivar JC, Dolan CE, Mora ME, Nuovo GJ, Cole SE, Viapiano MS.
    Cancer Res. 2012 Aug 1;72(15):3873-85. | Pubmed
  212. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
    Zhang X, Cowper-Sal Lari R, Bailey SD, Moore JH, Lupien M.
    Genome Res. 2012 Aug;22(8):1437-46. | Pubmed
  213. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype
    Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, Solomon KR, Adam RM, Isaacs WB, Higgs HN, Vessella RL, Di Vizio D, Freeman MR.
    EMBO Mol Med. 2012 Aug;4(8):743-60. | Pubmed
  214. DNA Damage Repair Pathways in Cancer Stem Cells
    Maugeri-Saccà M, Bartucci M, De Maria R.
    Mol Cancer Ther. 2012 Aug;11(8):1627-36. | Pubmed
  215. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B.
    Cancer Res. 2012 Aug 13. | Pubmed
  216. TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma.
    Huang HS, Liu ZM, Chen PC, Tseng HY, Yeh BW.
    Free Radic Biol Med. 2012 Aug 15;53(4):769-78. | Pubmed
  217. MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival
    Wernicke CM, Richter GH, Beinvogl BC, Plehm S, Schlitter AM, Bandapalli OR, Prazeres da Costa O, Hattenhorst UE, Volkmer I, Staege MS, Esposito I, Burdach S, Grunewald TG.
    Leuk Res. 2012 Sep;36(9):1185-92. | Pubmed
  218. Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
    Aung LL, Brooks A, Greenberg SA, Rosenberg ML, Dhib-Jalbut S, Balashov KE.
    J Neuroimmunol. 2012 Sep 15;250(1-2):99-105. | Pubmed
  219. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer
    Darrington RS, Campa VM, Walker MM, Bengoa-Vergniory N, Gorrono-Etxebarria I, Uysal-Onganer P, Kawano Y, Waxman J, Kypta RM.
    Int J Cancer. 2012 Sep 15;131(6):E872-83. | Pubmed
  220. Breaking the tolerance for tumor: Targeting negative regulators of TLR signaling
    Standiford TJ, Keshamouni VG
    OncoImmunology Volume 1, Issue 3 May/June 2012 Link
  221. Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth.
    Jääskeläinen T, Makkonen H, Visakorpi T, Kim J, Roeder RG, Palvimo JJ.
    Mol Cell Endocrinol. 2012 Mar 5;350(1):87-98. | Pubmed
  222. Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression
    Yang J, Staples O, Thomas LW, Briston T, Robson M, Poon E, Simões ML, El-Emir E, Buffa FM, Ahmed A, Annear NP, Shukla D, Pedley BR, Maxwell PH, Harris AL, Ashcroft M.
    J Clin Invest. 2012 Feb 1;122(2):600-11. | Pubmed
  223. Profiling of Antibody Production against Xenograft-released Proteins by Protein Microarrays Discovers Prostate Cancer Markers.
    Jansen FH, van Rijswijk A, Teubel W, van Weerden WM, Reneman S, van den Bemd GJ, Roobol MJ, Bangma CH, Staal FJ, Jenster G.
    J Proteome Res. 2012 Feb 3;11(2):728-35. | Pubmed
  224. The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres.
    Cabarcas SM, Thomas S, Zhang X, Cherry JM, Sebastian T, Yerramilli S, Lader E, Farrar WL, Hurt EM.
    Genomics. 2012 Feb;99(2):108-17. | Pubmed
  225. A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.
    Zhang K, Wong P, Zhang L, Jacobs B, Borden EC, Aster JC, Bedogni B.
    Oncogene. 2012 Jan 16. | Pubmed
  226. DNA methylation biomarker candidates for early detection of colon cancer.
    Yi JM, Dhir M, Guzzetta AA, Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM, Ahuja N.
    Tumour Biol. 2012 Jan 12. | Pubmed
  227. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis.
    Wong CC, Zhang H, Gilkes DM, Chen J, Wei H, Chaturvedi P, Hubbi ME, Semenza GL.
    J Mol Med (Berl). 2012 Jan 10. | Pubmed
  228. RNAi screening of the kinome with cytarabine in leukemias.
    Tibes R, Bogenberger JM, Chaudhuri L, Hagelstrom RT, Chow D, Buechel ME, Gonzales IM, Demuth T, Slack J, Mesa RA, Braggio E, Yin HH, Arora S, Azorsa DO.
    Blood. 2012 Jan 27. | Pubmed
  229. Combination of Haptoglobin and Osteopontin Could Predict Colorectal Cancer Hepatic Metastasis.
    Sun L, Pan J, Peng L, Fang L, Zhao X, Sun L, Yang Z, Ran Y.
    Ann Surg Oncol. 2012 Jan 5. | Pubmed
  230. Intersectin 1 is required for neuroblastoma tumorigenesis
    Russo A, O'Bryan JP.
    Oncogene. 2012 Jan 23 | Pubmed
  231. Expression and role in glycolysis of human ADP-dependent glucokinase.
    Richter S, Richter JP, Mehta SY, Gribble AM, Sutherland-Smith AJ, Stowell KM, Print CG, Ronimus RS, Wilson WR.
    Mol Cell Biochem. 2012 Jan 5. | Pubmed
  232. Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.
    Porter CC, Kim J, Fosmire S, Gearheart CM, van Linden A, Baturin D, Zaberezhnyy V, Patel PR, Gao D, Tan AC, Degregori J.
    Leukemia. 2012 Jan 13. | Pubmed
  233. MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells.
    Nadiminty N, Tummala R, Lou W, Zhu Y, Zhang J, Chen X, Devere White RW, Kung HJ, Evans CP, Gao AC.
    J Biol Chem. 2012 Jan 6;287(2):1527-37. | Pubmed
  234. Association of HADHA expression with the risk of breast cancer: targeted subset analysis and meta-analysis of microarray data.
    Mamtani M, Kulkarni H.
    BMC Res Notes. 2012 Jan 12;5:25. | Pubmed
  235. Critical role of O-GlcNAc transferase in prostate cancer invasion, angiogenesis and metastasis
    Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ.
    J Biol Chem. 2012 Jan 24. | Pubmed
  236. The p53-p21 (WAF1) checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function
    Lo PK, Lee JS, Sukumar S.
    Cell Signal. 2012 Jan;24(1):316-24. | Pubmed
  237. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
    Liu M, Chen LL, Chan TH, Wang J, Li Y, Li Y, Zeng TT, Yuan YF, Guan XY.
    Hepatology. 2012 Jan 19. | Pubmed
  238. Global analysis of DNA methylation in early-stage liver fibrosis
    Komatsu Y, Waku T, Iwasaki N, Ono W, Yamaguchi C, Yanagisawa J
    BMC Medical Genomics 2012, 5:5  | Pubmed
  239. Cadherin-11, a Marker of the Mesenchymal Phenotype, Regulates Glioblastoma Cell Migration and Survival In Vivo.
    Kaur H, Phillips-Mason PJ, Burden-Gulley SM, Kerstetter-Fogle AE, Basilion JP, Sloan AE, Brady-Kalnay SM.
    Mol Cancer Res. 2012 Jan 20. | Pubmed
  240. Differential Gene Expression between African American and European American Colorectal Cancer Patients
    Jovov B, Araujo-Perez F, Sigel CS, Stratford JK, McCoy AN, Yeh JJ, Keku T.
    PLoS One. 2012;7(1):e30168. | Pubmed
  241. Sequence and expression of the chicken membrane-associated phospholipases A1 alpha (LIPH) and beta (LIPI)
    Hesse M, Willscher E, Schmiedel BJ, Posch S, Golbik RP, Staege MS.
    Mol Biol Rep. 2012 Jan;39(1):761-9. | Pubmed
  242. Targeting protein lysine methylation and demethylation in cancers
    He Y, Korboukh I, Jin J, Huang J.
    Acta Biochim Biophys Sin (Shanghai). 2012 Jan;44(1):70-9. | Pubmed
  243. The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.
    Hawkins OE, Richmond A.
    Breast Cancer Res. 2012 Jan 26;14(1):103. | Pubmed
  244. Vitamin D and cancer: a review of molecular mechanisms
    Fleet JC, DeSmet M, Johnson R, Li Y.
    Biochem J. 2012 Jan 1;441(1):61-76. | Pubmed
  245. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
    Desai SD, Reed RE, Burks J, Wood LM, Pullikuth AK, Haas AL, Liu LF, Breslin JW, Meiners S, Sankar S.
    Exp Biol Med (Maywood). 2012 Jan 1;237(1):38-49. | Pubmed
  246. PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma.
    Brenner JC, Feng FY, Han S, Patel S, Goyal SV, Bou-Maroun LM, Liu M, Lonigro RJ, Prensner JR, Tomlins SA, Chinnaiyan AM.
    Cancer Res. 2012 Jan 27. | Pubmed
  247. HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells
    Belton A, Gabrovsky A, Bae YK, Reeves R, Iacobuzio-Donahue C, Huso DL, Resar LM.
    PLoS One. 2012;7(1):e30034. | Pubmed
  248. Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types
    Basu A, Rojas H, Banerjee H, Cabrera IB, Perez KY, De Leon M, Casiano CA.
    PLoS One. 2012;7(1):e30132. | Pubmed